SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-005300
Filing Date
2020-05-06
Accepted
2020-05-06 08:37:57
Documents
64
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vygr-20200506x10q.htm   iXBRL 10-Q 2097089
2 EX-31.1 vygr-20200331xex31d1.htm EX-31.1 12284
3 EX-31.2 vygr-20200331xex31d2.htm EX-31.2 12303
4 EX-32.1 vygr-20200331xex32d1.htm EX-32.1 10020
5 GRAPHIC vygr-20200506x10q006.jpg GRAPHIC 51119
  Complete submission text file 0001558370-20-005300.txt   7813588

Data Files

Seq Description Document Type Size
6 EX-101.SCH vygr-20200506.xsd EX-101.SCH 62769
7 EX-101.CAL vygr-20200506_cal.xml EX-101.CAL 51824
8 EX-101.DEF vygr-20200506_def.xml EX-101.DEF 234377
9 EX-101.LAB vygr-20200506_lab.xml EX-101.LAB 494311
10 EX-101.PRE vygr-20200506_pre.xml EX-101.PRE 392352
27 EXTRACTED XBRL INSTANCE DOCUMENT vygr-20200506x10q_htm.xml XML 1302886
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37625 | Film No.: 20851342
SIC: 2836 Biological Products, (No Diagnostic Substances)